Skip to main content

Research Topic

  • Low-cost moist heat treatment of N95 masks eliminates SARS-CoV-2, bacteria

    A new study shows that moist heat treatment of N95 masks eliminates severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and bacteria, which would allow reuse of these scarce resources. The study is published in CMAJ (Canadian Medical Association Journal).
  • Flu vaccination rate inching forward

    The influenza vaccination rate in Canada is moving in the right direction, but still well below target levels for high-risk groups.
  • AstraZeneca won't profit from COVID-19 vaccine in pandemic

    Pharmaceutical company AstraZeneca repeated its promise not to profit from a COVID-19 vaccine during the pandemic as it reported it was on track with late-stage trials for the treatment. Such promises were boosted by strong sales across its range of treatments during lockdown. Sales jumped by 14% to $12.6 billion in the first six months of 2020 and were helped by strong trading in new medicines, as well as cancer and respiratory medication.
  • Tam says feds, experts discussing COVID-19 vaccine orders amid concerns of delay

    Active discussions are taking place to potentially pre-order COVID-19 vaccine doses for Canadians, chief public health officer Dr. Theresa Tam said Tuesday. She said an independent vaccine task force is advising the government on options for Canada's choice of vaccine, including exploring the possibility of manufacturing a potential pandemic cure at home.
  • Parents divided over sending kids back to school: poll

    As the clock ticks down to September, a new poll suggests many Canadian parents are on the fence about whether to send their kids to school if and when classrooms are reopened. The poll by Leger and the Association for Canadian Studies comes as provincial governments are working on how to get students back into classrooms, most of which have been shuttered since mid-March due to COVID-19.
  • Scientists get closer to blood test for Alzheimer's disease

    The testing identified people with Alzheimer's vs. no dementia or other types of it with accuracy ranging from 89% to 98%
  • Senator urges Ottawa to support Canadian vaccine company awaiting funding

    An Alberta senator is urging Ottawa to fund a Canadian company so it can develop a domestic COVID-19 vaccine to lessen the risk Canadians will have wait in a line on a foreign-made pandemic cure. "I really do believe that we need to keep the pressure now on the government of Canada, whom I'm not criticizing. I get that this is an unusual time. And this may be in hand, or it may have fallen through the cracks. But we can't allow that to happen,'' Sen. Doug Black said in an interview Monday.
X
This ad will auto-close in 10 seconds